European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
Preservation of septal cartilage for early revisions: a histopathological study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hancı Deniz, Kumaş Ömer, Turgut Hüseyin, Çelik Cem, Uygan Uğur, Altun Hüseyin, Onaran Öykü İzel, Gürpınar Berk, Obuz Mert, Uyar Yavuz
Аннотация
OBJECTIVE: To determine how storage medium and temperature affect the histological viability of autologous septal cartilage intended for early revision rhinoplasty.
METHODS: Cartilage specimens stored for 6 and 12 months in four media-dry, gentamicin, cefazolin, and saline-at two distinct temperatures underwent histopathological evaluation after paraffin embedding. The assessed parameters were graft viability, fibrosis, osteoid metaplasia, and peripheral chondroid proliferation.
RESULTS: Among 480 septal cartilage specimens harvested from 30 patients, overall viability fell from 62 ± 15% at 6 months to 44 ± 14% at 12 months (p < 0.001), while fibrosis, osteoid metaplasia, and peripheral chondroid proliferation all increased significantly (each p < 0.001). Viability declined in every storage condition, but grafts kept at - 80 °C or in saline-based solutions deteriorated fastest, reaching a mean viability of 39% versus 53% for dry storage at - 20 °C at 12 months. Multivariate analysis confirmed - 80 °C storage (OR 2.3, 95% CI 1.4-3.8) and saline media (OR 1.9, 1.1-3.4) as independent predictors of poor viability (< 40%), whereas antibiotic additives were not protective. Histological evidence of osteoid metaplasia (OR 3.6, 1.9-6.8) and peripheral chondroid proliferation (OR 2.1, 1.2-3.7) strongly predicted non-viable grafts. A linear mixed-effects model demonstrated additive negative effects of - 80 °C and saline on both baseline viability and its rate of decline (marginal R² = 0.52). Dry storage at - 20 °C yielded the most favorable long-term viability.
CONCLUSION: Dry storage of autologous septal cartilage at - 20 °C preserves graft viability well enough to offer a cost-effective alternative for early revision surgeries, warranting confirmation in prospective clinical trials.
METHODS: Cartilage specimens stored for 6 and 12 months in four media-dry, gentamicin, cefazolin, and saline-at two distinct temperatures underwent histopathological evaluation after paraffin embedding. The assessed parameters were graft viability, fibrosis, osteoid metaplasia, and peripheral chondroid proliferation.
RESULTS: Among 480 septal cartilage specimens harvested from 30 patients, overall viability fell from 62 ± 15% at 6 months to 44 ± 14% at 12 months (p < 0.001), while fibrosis, osteoid metaplasia, and peripheral chondroid proliferation all increased significantly (each p < 0.001). Viability declined in every storage condition, but grafts kept at - 80 °C or in saline-based solutions deteriorated fastest, reaching a mean viability of 39% versus 53% for dry storage at - 20 °C at 12 months. Multivariate analysis confirmed - 80 °C storage (OR 2.3, 95% CI 1.4-3.8) and saline media (OR 1.9, 1.1-3.4) as independent predictors of poor viability (< 40%), whereas antibiotic additives were not protective. Histological evidence of osteoid metaplasia (OR 3.6, 1.9-6.8) and peripheral chondroid proliferation (OR 2.1, 1.2-3.7) strongly predicted non-viable grafts. A linear mixed-effects model demonstrated additive negative effects of - 80 °C and saline on both baseline viability and its rate of decline (marginal R² = 0.52). Dry storage at - 20 °C yielded the most favorable long-term viability.
CONCLUSION: Dry storage of autologous septal cartilage at - 20 °C preserves graft viability well enough to offer a cost-effective alternative for early revision surgeries, warranting confirmation in prospective clinical trials.